365106250	365106250	CD	B-NP	O
|	|	NN	I-NP	O
EMC	EMC	NN	I-NP	O
|	|	NN	I-NP	O
80689410	80689410	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0835419	0835419	CD	B-NP	O
|	|	CC	I-NP	O
9/27/2005	9/27/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Angina	Angina	NNP	I-NP	O
,	,	,	O	O
R/o	R/o	NNP	B-NP	O
MI	MI	NNP	I-NP	O
.	.	.	O	O

|	|	LS	B-LST	O
|	|	:	O	B-cell_type
DIS	DIS	NNP	B-NP	I-cell_type
|	|	NNP	I-NP	I-cell_type
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/26/2005	6/26/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2005	7/15/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
CONTINENZA	CONTINENZA	NNP	B-NP	O
,	,	,	O	O
WHITNEY	WHITNEY	NNP	B-NP	O
A.	A.	NNP	I-NP	O
678-61-28-1	678-61-28-1	NNP	I-NP	O
Rock	Rock	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/18/05	10/18/05	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BIRKEY	BIRKEY	NNP	B-NP	O
,	,	,	O	O
MERLIN	MERLIN	NNP	B-NP	O
KEVEN	KEVEN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HYDRALAZINE	HYDRALAZINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
90	90	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
1/3	1/3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
95	95	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

LABETALOL	LABETALOL	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
600	600	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
CLARITIN	CLARITIN	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
LORATADINE	LORATADINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
COZAAR	COZAAR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
LOSARTAN	LOSARTAN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
95	95	CD	I-NP	I-protein
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
850	850	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
VYTORIN	VYTORIN	NNP	I-NP	O
10/40	10/40	CD	I-NP	O
-LRB-	-LRB-	SYM	O	O
EZETIMIBE	EZETIMIBE	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	B-protein
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Rob	Rob	NNP	I-NP	O
Mulroy	Mulroy	NNP	I-NP	O
1	1	CD	I-NP	O
wk	wk	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Latex	Latex	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atypical	Atypical	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
HTN	HTN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	:	O	O
NIDDM	NIDDM	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NN	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
Renal	Renal	NNP	I-NP	O
Cell	Cell	NNP	I-NP	O
Carcinoma	Carcinoma	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Angina	Angina	NNP	I-NP	O
,	,	,	O	O
R/o	R/o	NNP	B-NP	O
MI	MI	NNP	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HYPERTENSION	HYPERTENSION	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
MVA	MVA	NN	I-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
RLE	RLE	NN	I-NP	B-protein
FRX	FRX	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	O
1977	1977	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
S/P	S/P	NN	I-NP	O
RLE	RLE	NN	I-NP	O
SKIN	SKIN	NN	I-NP	O
GRAFT	GRAFT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
1977	1977	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
NON-COMPLIANCE	NON-COMPLIANCE	NNP	I-NP	O
OBESITY	OBESITY	NNP	I-NP	O
?	?	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Adenosine	Adenosine	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NNP	B-NP	O
Preliminary	Preliminary	NNP	I-NP	O
report	report	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Poor	Poor	NNP	I-NP	O
quality	quality	NN	I-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

LVEF	LVEF	NN	B-NP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

LV	LV	NN	B-NP	O
dilated	dilate	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
43	43	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w/hx	w/hx	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
p/w	p/w	NN	I-NP	O
atypical	atypical	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

P/w	P/w	NN	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
h/o	h/o	NN	I-NP	O
L	L	NN	I-NP	O
sided	side	VBD	B-VP	O
dull	dull	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
L	L	NN	I-NP	O
arm	arm	NN	I-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
5/10	5/10	CD	B-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
hrs	hr	NNS	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
Diaphoresis	Diaphoresis	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
RF	RF	NN	I-NP	I-protein
include	include	VBP	B-VP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hyperchol	Hyperchol	NN	B-NP	O
,	,	,	O	O
FH	FH	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

TnI	TnI	NN	B-NP	B-protein
at	at	IN	B-PP	O
ASH	ASH	NN	B-NP	O
neg	neg	NN	I-NP	O
-	-	HYPH	B-NP	O
0.04	0.04	CD	I-NP	O
and	and	CC	I-NP	O
0.05	0.05	CD	I-NP	O
but	but	CC	O	O
continued	continue	VBD	B-VP	O
pain	pain	NN	B-NP	O
requiring	require	VBG	B-VP	O
NTG	NTG	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
with	with	IN	B-PP	O
TWI	TWI	NN	B-NP	O
concerning	concerning	NN	I-NP	O
for	for	IN	B-PP	O
anterolateral	anterolateral	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Initiated	Initiate	VBN	B-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
M	M	NN	B-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
dxed	dxe	VBD	B-VP	O
1997	1997	CD	B-NP	O
while	while	IN	B-SBAR	O
actively	actively	RB	B-ADVP	O
using	use	VBG	B-VP	O
cocaine	cocaine	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hypercholesterolemia	Hypercholesterolemia	NNP	B-NP	O
,	,	,	O	O
Renal	Renal	NNP	B-NP	O
Cell	Cell	NNP	I-NP	O
Carcinoma	Carcinoma	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Status	Status	NN	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
T100	T100	NN	I-NP	I-DNA
.5	.5	CD	B-NP	I-DNA
P	P	NN	I-NP	I-DNA
82	82	CD	B-NP	I-DNA
R	R	NN	I-NP	I-DNA
18	18	CD	B-NP	I-DNA
BP	BP	NN	I-NP	I-DNA
148/70	148/70	CD	B-NP	I-DNA
Pox	Pox	NNP	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

Gen	Gen	NN	B-NP	O
:	:	:	O	O
Pleaseant	Pleaseant	JJ	B-NP	O
obese	obese	JJ	I-NP	O
M	M	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
I/VI	I/VI	NNP	B-NP	O
SEM	SEM	NNP	I-NP	O
LSB	LSB	NNP	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
S3	S3	NN	I-NP	O
.	.	.	O	O

Resp	Resp	NN	B-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
Ab	Ab	NN	B-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT	NT	JJ	I-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
distended	distend	VBN	I-NP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
:	:	:	O	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
bilateral	bilateral	JJ	B-ADJP	O
.	.	.	O	O

Guaic	Guaic	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
stool	stool	NN	I-NP	O
in	in	IN	B-PP	O
vault	vault	NN	B-NP	O
.	.	.	O	O

--	--	:	B-NP	O
Procedures/Tests	Procedures/Test	NNS	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	O
:	:	:	O	O
Trop	Trop	NN	B-NP	O
OSH	OSH	NN	I-NP	O
0.04	0.04	CD	I-NP	O
,	,	,	I-NP	O
0.05	0.05	CD	I-NP	O
,	,	,	O	O
K2	K2	NN	B-NP	B-cell_line
.9	.9	CD	I-NP	I-cell_line
,	,	,	O	O
Hct	Hct	NNP	B-NP	O
35.5	35.5	CD	I-NP	O
,	,	,	O	O
creat	creat	NN	B-NP	O
2.0	2.0	CD	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
with	with	IN	B-PP	O
repolarization	repolarization	NN	B-NP	O
,	,	,	O	O
TWI	TWI	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
V4-6	V4-6	NNP	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
9/16	9/16	CD	B-NP	O
:	:	:	O	O
Cardiomegaly	Cardiomegaly	NNP	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
pul	pul	NN	I-NP	O
vasculature	vasculature	NN	I-NP	O
engorgement	engorgement	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
pul	pul	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Adenosine	Adenosine	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
10/18	10/18	CD	B-NP	O
Poor	Poor	NN	I-NP	O
quality	quality	NN	I-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

LV	LV	NN	B-NP	O
dilated	dilate	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
A/P	A/P	NN	B-NP	O
:	:	:	O	O
43	43	CD	B-NP	O
M	M	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Concern	Concern	NN	B-NP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina/NSTEMI	angina/NSTEMI	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
ISCHEMIA	ISCHEMIA	NN	I-NP	O
:	:	:	O	O
significant	significant	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
hx	hx	NN	I-NP	O
with	with	IN	B-PP	O
borderline	borderline	JJ	B-NP	O
TNI	TNI	NN	I-NP	O
at	at	IN	B-PP	O
ASH	ASH	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
0.04-0	0.04-0	CD	B-NP	O
.05	.05	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
to	to	TO	B-PP	O
WO	WO	NNP	B-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
labetalol	labetalol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
ARB	ARB	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ANGIOEDEMA	ANGIOEDEMA	NN	I-NP	I-protein
w/ACE	w/ACE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
,	,	,	O	O
O2	O2	NN	B-NP	O
.	.	.	O	O

Remained	Remain	VBN	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	I-NP	O
overnight	overnight	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/10	9/10	CD	B-NP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
tapered	taper	VBD	B-VP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
and	and	CC	I-NP	O
labetalol	labetalol	NN	I-NP	O
increased	increase	VBD	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
MIBI	MIBI	NNP	B-NP	O
,	,	,	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
LV	LV	NN	B-NP	O
dilation	dilation	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
remained	remain	VBD	B-VP	O
overnight	overnight	JJ	B-ADJP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
BP	BP	NN	I-NP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
continued	continued	JJ	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
antihypertensives	antihypertensive	NNS	B-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
:	:	:	O	O
euvolemic	euvolemic	JJ	B-ADJP	O
;	;	:	O	O
LVEF	LVEF	NN	B-NP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
via	via	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	I-PP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
Cr	Cr	NN	I-NP	O
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
dose	dose	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Metformin	Metformin	NNP	B-NP	O
held	hold	VBD	B-VP	O
,	,	,	O	O
NPH	NPH	NNP	B-NP	O
and	and	CC	O	O
Novolog	Novolog	NNP	B-NP	O
SSI	SSI	NNP	I-NP	O
initiated	initiate	VBD	B-VP	O
for	for	IN	B-PP	O
BS	BS	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

FS	FS	NN	B-NP	O
AC	AC	NN	I-NP	O
,	,	,	O	O
excellent	excellent	JJ	B-NP	O
BS	BS	NN	I-NP	O
with	with	IN	B-PP	O
range	range	NN	B-NP	B-protein
110-150	110-150	CD	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
temps	temp	NNS	I-NP	O
-	-	HYPH	B-NP	O
UA	UA	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
h/o	h/o	NN	B-NP	O
hematochezia	hematochezia	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
stool	stool	NN	I-NP	O
on	on	IN	B-PP	O
DRE	DRE	NN	B-NP	B-DNA
.	.	.	O	O

Guiac	Guiac	JJ	B-NP	O
stools	stool	NNS	I-NP	O
x	x	VBP	B-VP	O
3	3	CD	B-NP	O
as	as	IN	B-PP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
SLIV	SLIV	NN	B-NP	O
.	.	.	O	O

Replete	Replete	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
aggressively	aggressively	RB	B-ADVP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Resp	Resp	NN	B-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

Supp	Supp	NNP	B-NP	O
O2	O2	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
FULL	FULL	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Racioppo	Racioppo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
925	925	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
590	590	CD	I-NP	O
4260	4260	CD	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appt	appt	NN	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
.	.	.	O	O

Bring	Bring	VBG	B-VP	O
this	this	DT	B-NP	O
document	document	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
appt	appt	NN	I-NP	O
.	.	.	O	O

Comply	Comply	RB	B-ADVP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
chol	chol	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
<	<	SYM	B-NP	O
2g	2g	CD	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
gain	gain	VBP	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
or	or	CC	O	O
5	5	CD	B-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
contact	contact	NN	I-NP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
symptom	symptom	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
advised	advise	VBN	B-VP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
resume	resume	VB	I-VP	O
the	the	DT	B-NP	O
Norvasc	Norvasc	NNP	I-NP	O
or	or	CC	I-NP	O
Enalapril	Enalapril	NNP	I-NP	O
until	until	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
so	so	RB	B-ADVP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kozola	Kozola	NNP	I-NP	O
.	.	.	O	O

Seek	Seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
marked	marked	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
F/u	F/u	NNP	I-NP	O
with	with	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Pulfrey	Pulfrey	NNP	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
check	check	NN	I-NP	O
.	.	.	O	O

May	May	MD	O	O
need	need	VBP	B-VP	O
medication	medication	NN	B-NP	O
titration	titration	NN	I-NP	O
including	include	VBG	B-PP	O
reinstitution	reinstitution	NN	B-NP	O
of	of	IN	B-PP	O
Norvasc.Consider	Norvasc.Consider	NNP	B-NP	O
further	further	JJ	I-NP	O
w/u	w/u	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
IDA	IDA	NN	I-NP	B-protein
+	+	SYM	O	O
/	/	SYM	O	O
-	-	HYPH	O	O
AOCD	AOCD	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
hematochezia	hematochezia	NN	I-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
prior	prior	JJ	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BERNT	BERNT	NNP	B-NP	O
,	,	,	O	O
SHON	SHON	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OJ43	OJ43	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/18/05	10/18/05	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
38	38	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

